Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma

Citation
P. Ragazzini et al., Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma, CANCER DET, 23(2), 1999, pp. 129-136
Citations number
30
Categorie Soggetti
Oncology
Journal title
CANCER DETECTION AND PREVENTION
ISSN journal
0361090X → ACNP
Volume
23
Issue
2
Year of publication
1999
Pages
129 - 136
Database
ISI
SICI code
0361-090X(1999)23:2<129:AOSGAC>2.0.ZU;2-6
Abstract
The region q13-15 of chromosome 12 contains SAS, CDK4, and MDM2 genes that are rearranged or amplified in a variety of human sarcomas. This study eval uated SAS gene amplification, and MDM2 and CDK4 protein expression in 20 tu mor samples of central low-grade osteosarcoma (16 primary, 3 recurrences, 1 lung metastasis). SAS amplification was analyzed by quantitative polymeras e chain reaction (PCR), while from the same paraffin-embedded samples, MDM2 and CDK4 protein expression was evaluated by immunohistochemistry. MDM2 an d CDK4 proteins were found strongly expressed in 35% and 65%, respectively, of the samples. SAS was found amplified in 15% of the samples. These findi ngs indicate that these genes may be involved in tumorigenesis and progress ion of low-grade osteosarcoma.